ASX - By Stock
|
PER |
Re:
Webinar 25th November
|
|
koenermann
|
111 |
36K |
7 |
25/11/21 |
25/11/21 |
ASX - By Stock
|
111
|
36K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Webinar TOMORROW 12:30pm Sydney with CEO, Chair & NED!
|
|
koenermann
|
110 |
26K |
4 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
110
|
26K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Webinar TOMORROW 12:30pm Sydney with CEO, Chair & NED!
|
|
koenermann
|
110 |
26K |
2 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
110
|
26K
|
2
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
koenermann
|
855 |
236K |
1 |
23/11/21 |
23/11/21 |
ASX - By Stock
|
855
|
236K
|
1
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
koenermann
|
855 |
236K |
3 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
855
|
236K
|
3
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
koenermann
|
855 |
236K |
18 |
19/11/21 |
19/11/21 |
ASX - By Stock
|
855
|
236K
|
18
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
koenermann
|
855 |
236K |
1 |
18/11/21 |
18/11/21 |
ASX - By Stock
|
855
|
236K
|
1
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
koenermann
|
855 |
236K |
0 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
855
|
236K
|
0
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
koenermann
|
855 |
236K |
1 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
855
|
236K
|
1
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
koenermann
|
855 |
236K |
6 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
855
|
236K
|
6
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
koenermann
|
855 |
236K |
1 |
17/11/21 |
17/11/21 |
ASX - By Stock
|
855
|
236K
|
1
|
|
ASX - By Stock
|
PER |
Re:
CEO Mark Diamond on SC webinar @ 12:30pm TODAY
|
|
koenermann
|
51 |
16K |
6 |
13/11/21 |
13/11/21 |
ASX - By Stock
|
51
|
16K
|
6
|
|
ASX - By Stock
|
PER |
Re:
$15m cap raise Fresh Equities at 24c
|
|
koenermann
|
855 |
236K |
0 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
855
|
236K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Report and Appendix 4C
|
|
koenermann
|
24 |
8.0K |
3 |
30/10/21 |
30/10/21 |
ASX - By Stock
|
24
|
8.0K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Report and Appendix 4C
|
|
koenermann
|
24 |
8.0K |
4 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
24
|
8.0K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Trading Halt
|
|
koenermann
|
143 |
50K |
7 |
28/10/21 |
28/10/21 |
ASX - By Stock
|
143
|
50K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
6 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
1.0K
|
364K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
24 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
1.0K
|
364K
|
24
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
1 |
26/10/21 |
26/10/21 |
ASX - By Stock
|
1.0K
|
364K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
7 |
16/10/21 |
16/10/21 |
ASX - By Stock
|
1.0K
|
364K
|
7
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
0 |
15/10/21 |
15/10/21 |
ASX - By Stock
|
1.0K
|
364K
|
0
|
|
Charts
|
PER |
Re:
Chart
|
|
koenermann
|
5.9K |
2.3M |
8 |
15/10/21 |
15/10/21 |
Charts
|
5.9K
|
2.3M
|
8
|
|
Charts
|
PER |
Re:
Chart
|
|
koenermann
|
5.9K |
2.3M |
4 |
13/10/21 |
13/10/21 |
Charts
|
5.9K
|
2.3M
|
4
|
|
Charts
|
PER |
Re:
Chart
|
|
koenermann
|
5.9K |
2.3M |
3 |
13/10/21 |
13/10/21 |
Charts
|
5.9K
|
2.3M
|
3
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
5 |
12/10/21 |
12/10/21 |
ASX - By Stock
|
1.0K
|
364K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive feedback received on Paediatric Investigation Plan
|
|
koenermann
|
221 |
80K |
5 |
06/10/21 |
06/10/21 |
ASX - By Stock
|
221
|
80K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Positive feedback received on Paediatric Investigation Plan
|
|
koenermann
|
221 |
80K |
10 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
221
|
80K
|
10
|
|
ASX - By Stock
|
PER |
Re:
Ann: New data supports ATL1102s broader clinical potential
|
|
koenermann
|
66 |
24K |
9 |
26/09/21 |
26/09/21 |
ASX - By Stock
|
66
|
24K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
2 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
1.0K
|
364K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
0 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
1.0K
|
364K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
0 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
1.0K
|
364K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
6 |
15/09/21 |
15/09/21 |
ASX - By Stock
|
1.0K
|
364K
|
6
|
|
ASX - By Stock
|
PER |
Re:
Where others have failed will Atl1102 succeed ?
|
|
koenermann
|
1.0K |
364K |
2 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
1.0K
|
364K
|
2
|
|